The Centers for Medicare & Medicaid Services Aug. 15 released a state funding notice for the Cell and Gene Therapy Access Model. The CGT Access Model will test whether a CMS-led approach to developing and administering outcomes-based agreements for cell and gene therapies improves Medicaid beneficiaries’ health outcomes, broadens access to innovative treatment and reduces health care expenditures. It will initially focus on gene therapies for sickle cell disease. The notice includes an opportunity for applicants to apply for cooperative agreement funding to support participation in the CGT Access Model. Applicants must apply for participation in the model through a state applications request and apply for funding through the state funding notice, both of which are due Feb. 28, 2025. The award date is anticipated for July 1, 2025. 

Related News Articles

Headline
The Senate Finance Committee March 14 held a confirmation hearing on Mehmet Oz's nomination for administrator of the Centers for Medicare & Medicaid…
Headline
The Centers for Medicare & Medicaid Services March 12 announced that it will end four payment models early, terminating each by the end of 2025. The models…
Perspective
Public
With March kicking off tomorrow, we’re approaching March Madness when college basketball teams across the country compete in the annual tournament that often…
Headline
The House of Representatives last night voted 217-215 to adopt its budget proposal that calls for $2 trillion in spending cuts, some of which could potentially…
Headline
AHA President and CEO Rick Pollack today said the House of Representatives should construct a path forward on budget reconciliation that “protects Medicaid…
Headline
The Coalition to Strengthen America's Healthcare today launched a new national advertising campaign highlighting Medicaid's impact on the more than 72 million…